Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13454 |
(S)-Purvalanol B
(S)-NG 95 |
BCL | Apoptosis |
(S)-Purvalanol B 是 Purvalanol B 的 S 对映体,Purvalanol B 是一种细胞周期蛋白依赖性激酶(CDK)抑制剂。 | |||
T71230 |
VMY-1-103
|
||
VMY-1-103 is a potent CDK inhibitor, is also a novel dansylated analog of purvalanol B, was shown to inhibit cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B. VMY-1-103 , but not purvalanol B, significantly decreased the proportion of cells in S phase and increased the proportion of cells in G(2)/M. VMY-1-103 increased the sub G(1) fraction of apoptotic cells, induced PARP and caspase-3 cleavage and increased the levels of the Death ... |